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Abstract. The Lycopodium alkaloids are a structurally diverse 
group of natural products isolated from Lycopodium with 
important biological effects for the potential treatment of cancer 
and severe neurodegenerative diseases. To date, full biological 
studies have been hampered by lack of material from natural 
sources. Total synthesis represents a possible solution to meet 
this demand as well as the most effective way to design new 
compounds to determine structural activity relationships and 
obtain more potent compounds. The aim of this chapter is to 
summarise the work carried out in this field so far by presenting 
an overview of the synthetic strategies used to access each of the 
four key Lycopodium alkaloid types. Particular emphasis has 
been placed on methods that rapidly construct each nucleus 
utilizing tandem reactions.  
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1. Introduction 
 
 The Lycopodium alkaloids, isolated from the Lycopodium genus of 
clubmosses belonging to the family of Lycopodiaceae, represent a diverse 
group of structures with important, wide-ranging biological effects. These 
compounds show great potential for the treatment of severe 
neurodegenerative diseases and cancers but to date biological studies have 
been hindered due to limited availability of material from natural sources. 
Attempts to access material via cultivation or fermentation have so far been 
unsuccessful [1] leaving total synthesis as the most promising way to access 
quantities of material for further biological testing. In addition, synthesis has 
the advantage that it easily enables structural modifications to be carried out 
to determine activity relationships and as a consequence design more potent 
analogues with improved biological profiles. The aim of this minireview is to 
give an overview of the synthetic strategies used to access each type of key 
Lycopodium alkaloids with particular emphasis on those synthetic 
approaches that feature tandem reactions enabling a rapid synthesis of each 
nucleus. Whilst a brief overview of the structures, biological properties and 
biosynthesis will be presented for contextual purposes, the authors direct the 
reader to the excellent review by Ma [1] for a more detailed coverage of these 
aspects. 
 
1.1. Classification of the Lycopodium alkaloids 
  
 At the moment of writing this report almost 300 Lycopodium alkaloids 
have been discovered [2] which can be divided into four structural classes 
[3,4] based on the parent compound: phlegmarine (1), lycopodine (2), 
lycodine (3) and fawcettimine (4) (Fig. 1).   
 
 
 
 
Figure 1. Representative examples of the four Lycopodium alkaloid classes. 
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1.2 . Bioactivities  
 
 An extensive biological investigation of the Lycopodium alkaloids has as 
yet not been carried out. However, from the limited studies undertaken so far 
it has been discovered that many of these compounds possess important 
biological activities that warrant further investigation and development. One 
key area of potential of these compounds is for the treatment of severe 
neurodegenerative diseases such as Alzheimer’s. Examples include huperzine A 
[5] and lycoposerramine C [6], which act as inhibitors of the enzyme 
acetylcholinesterase (AChE), while lycodine-type complanadine B stimulates 
nerve growth factor (NGF) production in human glial cells [7]. 
Lycoposerramine Z from the phlegmarine structural class may potentially 
have neuroprotective properties due to the presence of the nitrone moiety, 
which can act as a free radical trap [8]
 
helping prevent destructive cascades 
leading to brain deterioration (Fig. 2). 
 The Lycopodium alkaloids have also been shown to possess anticancer 
activities. For example, complanadine A was found to be cytotoxic against 
leukaemia cells in mice [9]. Lyconadine B, from the phlegmarine group 
exhibits biological activity against brain tumors [10] and lycopodine has the 
ability to bring about inhibition in the growth of HeLa55 cells [11]. 
 
 
 
Figure 2. Some biologically active Lycopodium alkaloids. 
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1.3. Biosynthesis of the Lycopodium alkaloids  
 
 The biosynthetic pathway leading to all Lycopodium alkaloids is still 
not clear, although a basic overview is outlined in Scheme 1 based on the 
present knowledge [1]. The vast structural diversity encountered among the 
Lycopodium alkaloids is thought to derive from just two simple 
components, lysine and malonyl Co-A. The entry point into the pathway is 
through the decarboxylation of lysine to form cadaverine
 
which is 
transformed to Δ1-piperideine. At the same time, two molecules of malonyl-
CoA are condensed to form acetonedicarboxylic acid, whose union with  
Δ1-piperideine leads to 4-(2-piperidyl) acetoacetate (4PAA). This is then 
decarboxylated to form pelletierine, which is coupled to another molecule 
of 4PAA to form the phlegmarine-type Lycopodium alkaloids. These 
compounds are formed with multiple stereochemistries that can be 
separated into two main classes depending on whether the hydrogens at the 
ring fusion are arranged cis or trans (see section 2). It is assumed that on 
dimerisation slightly different pathways exist with different methods of 
control thus leading to the diverse range of stereochemistries observed. 
Phlegmarine (1) which is characterized by a trans fusion at the ring 
junction is considered to be the key intermediate from which the other three 
classes (2-4) of Lycopodium alkaloids are derived. Bond formation between 
C-4 and C-13 gives the lycodane skeleton, which after oxidation of the 
piperidine ring leads to lycodine (3). Detachment of C-1 from Nα of the 
lycodane skeleton and reattachment to Nβ then gives lycopodine (2). 
Rearrangement of (2) via migration of the C-4 to C-13 bond to C-12 forms 
the 5-membered ring of fawcettimine (4). Further complexity within each 
of these groups is arrived at by a series of modifications of these basic ring 
structures such as oxidations, ring fragmentations, dimerisations and 
additional skeletal rearrangements. 
 The cis-fused phlegmarine alkaloids comprise the entry point to the 
miscellaneous class of the lycopodium alkaloids, including compounds 
such as lyconadine A or dihydroluciduline which maintain the same cis 
stereochemistry relationship as the parent compound. Cernuine and related 
quinazoline Lycopodium alkaloids are speculated to arise from an opening 
of the B ring of the phlegmarine skeleton, additional oxidation, followed by 
a 4+2 cycloaddition reaction.  Due to the loss of the fusion stereochemistry, 
these compounds may arise via the trans or cis phlegmarine group 
intermediates.  
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Scheme 1. Overview of the biosynthesis of the Lycopodium alkaloids. 
Ben Bradshaw et al. 148 
2. Phlegmarine class 
 
 Phlegmarine is the parent member of the miscellaneous group of the 
Lycopodium alkaloids and as mentioned above, is considered to play a key 
role in the biosynthesis of all the lycopodium alkaloids. While phlegmarine 
(1) is characterized by a trans substitution pattern at the ring fusion carbons, 
other compounds belonging to this group feature a cis relationship between 
the ring fusion hydrogens (e.g lycoposerramine Z and cermizine B). In 
addition to the wide variety of stereochemistries observed, other key 
variations are the oxidation of the nitrogen containing rings leading to 
pyridines (lycoposerramine V and W), nitrones (huperzine M and 
lycoposerramine Z) or N-oxides (huperzine N) (Fig. 3).  
 
 
 
Figure 3. Representative compounds of the miscellaneous class based on the 
phlegmarine skeleton. 
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2.1. Previous synthesis of Phlegmarine type alkaloids   
 
 Despite the importance of this class of compounds from a biosynthetic 
point of view and their potential for use as biomimetic precursors of the other 
classes of Lycopodium alkaloids, the phlegmarine type has been one of the 
least studied (Table 1). Although the relative configuration of phlegmarine 
was established in 1981 [12] the absolute configuration of a phlegmarine 
derivative was not determined until 1999 [13] when Comins et al carried out 
the first asymmetric total synthesis of Nα-acetyl-Nβ-methylphlegmarine using 
a pyridine auxiliary for the construction of both the C and A nitrogen-
containing rings. Takayama's enantioselective syntheses of lycoposerramines 
V, W [14], X and Z [15] were accomplished using (5R)-methyl-2-
cyclohexenone as the source of chirality. Comins then completed the 
synthesis of phlegmarine in 2010 [16] based on his original methodology and 
finally, the Bonjoch group utilized organocatalysis to form the 
decahydroquinoline ring system as the key step.[17] 
 
Table 1. Previous synthesis of some Phlegmarine-type Lycopodium alkaloids 
(*denotes enantioselective synthesis). 
 
Year Natural Product 
 
Author         Ring Construction                                                     
Strategy 
1981 [12] Nα-methyl-Nβ-acetylphlegmarine Maclean B→C→A 
1999 [13] Nα-acetyl-Nβ-methylphlegmarine Comins C→B→A* 
2007 [14] Lycoposerramine-V 
+(Lycoposerramine W) 
Takayama B→C→A* 
2009 [15] Lycoposerramine-X 
+(Lycoposerramine Z) 
Takayama B→C→A* 
 
2010 [16]  ( )-Phlegmarine and derivatives Comins C→B→A* 
2013 [17] Lycoposerramine-Z Bonjoch acyclic→BC→A* 
 
2.2. Bonjoch's synthesis of Lycoposerramine Z [17] 
 
 Bonjoch’s group developed an asymmetric synthesis of 
lycoposerramine Z, where the decahydroquinoline core was assembled via 
an organocatalyzed diastereo and enantioselective one-pot tandem 
procedure (Scheme 2). Removal of the tert butyl ester group with TFA and 
coupling with pyridine phosphonate 5 assembled the complete carbon 
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skeleton in a rapid manner. Hydrogenation of alkene 6 took place 
exclusively from the top face leading to 7, which has all the stereocentres 
required for lycoposerramine Z in place. The sensitive nature of the nitrone 
unit necessitated exchange of the tosyl group for the more readily labile 
Teoc group (trimethylsilylethylcarbonate), which was previously used in 
Takayama's synthesis of the same compound. Finally reduction of the 
pyridine ring followed by oxidation with Na2WO4 in the presence of urea 
peroxide installed the nitrone unit. Treatment with TFA smoothly removed 
the Teoc group to complete the synthesis.  
 It was also later shown that this method can be adapted to access all the 
different core decahydroquinoline stereochemistries present in the 
phlegmarine group via a series of controlled equilibration reactions [18]. 
 
 
 
Scheme 2. Bonjoch’s total synthesis of Lycoposerramine Z. 
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3. Lycodine class  
 
 The lycodine (3) group comprises around 30 of the 300 known 
Lycopodium alkaloids. Some examples are shown in Fig. 4. Complanadine A 
is a dimer of two lycodine units. Hydroxypropyllycodine is the first 
Lycopodium alkaloid found to possess a 19-carbon skeleton [19]. In some 
compounds such as huperzines A and B the D ring is unsaturated whilst in 
the former the C ring has been cleaved. Casuaririne I features an 
unprecedented 5-membered tetrahydropyrrole ring and is believed to derive 
from huperzine A [20]. 
 
 
 
Figure 4. Representative compounds of the Lycodine group. 
 
3.1. Previous synthesis of Lycodine and related compounds 
 
 Along with the phlegmarine group, the synthesis of the lycodine class has 
been the least studied. The D→C→B→A ring strategy is the most commonly 
used to construct the lycodine nucleus. The first synthesis of (±)-lycodine was 
performed by Heathcock [21],
 
who closed the DCB skeleton in a one-pot 
diastereoselective Mannich condensation. Another racemic synthesis of 
lycodine was developed by Hirama [22] and involved a Diels-Alder 
cycloaddition followed by an intramolecular Mizoroki-Heck reaction to 
furnish the complete skeleton. In Sarpong’s complanadine A synthesis [23] 
Boc-protected lycodine was prepared as a key intermediate en route to the  
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Table 2. Previous syntheses of Lycodine and its dimer's Complanadine A and B.                 
(* denotes enantioselective synthesis). 
 
Year Natural Product Author                    Ring Construction 
Strategy 
1982 [21] Lycodine Heathcock D→C→B→A 
2010 [22] Lycodine Hirama acyclic→CD→BA 
2010 [23] Complanadine A Sarpong D→DCBA* 
2010 [25] Complanadine A Siegel D→C→B→A* 
2013 [24] Complanadine B Sarpong D→DCBA 
2013 [26] Complanadines A/B Hirama acyclic→CD→BA 
 
final product in enantiopure form (see Scheme 3). This same key 
intermediate was later used in his synthesis of complanadine B [24].
 
Seigel 
[25] made use of two Co-mediated [2+2+2] cycloaddition reactions to furnish 
complanadine B starting from a thioether derivative of (5R)-methyl-2-
cyclohexenone. While as yet no enantioselective synthesis of lycodine has 
been described, recently Hirama [26] and co-workers reported the synthesis 
of Complanadines A and B starting from enantiopure ( )-lycodine, which 
was obtained by chiral HPLC separation.   
 
3.2. Sarpong’s synthesis of complanadine A [23] 
 
 Sarpongs´s synthesis of complanadine A takes advantage of the 
symmetry of the product to construct the dimer from two lycodine units via a 
palladium-based coupling reaction as the key step.  Preparation of the (5R)-
methyl-2-cyclohexenone starting material 8 was accomplished in 3 steps 
from R-(+)-pulegone using a reported procedure [27]. Iodination and radical 
addition to acrylonitrile gave 9 which after acetalization and reduction of the 
nitrile gave 10 the key material for the subsequent tandem cyclisation 
reaction. Treatment of this compound with perchloric acid led to an 
intermediate that was trapped with an enamide 11 via a Michael-Mannich 
tandem procedure to furnish the DCB core [28] followed by condensation of 
the amide to the carbonyl formed the A ring giving a rapid synthesis of the 
complete lycodine skeleton (Scheme 3). Protection of the resulting compound 
followed by oxidation with lead tetraacetate and triflation of the pyridone 
ring provided 12. Removal of the triflate group gave Boc-protected lycodine 
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13 to which was introduced a boronic ester with an iridium-catalyzed 
functionalization at the 3 position to give 14.  Finally, Suzuki cross-coupling 
of 12 and 14 followed by cleavage of the Boc protecting groups completed 
the synthesis. 
 
 
 
Scheme 3. Sarpong's total synthesis of complanadine A. 
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4. Lycopodine class  
  
 Lycopodine (Fig. 5), the first isolated Lycopodium alkaloid [29], is the 
most widespread and can be found in several different Lycopodium species. 
Out of the 300 known Lycopodium alkaloids discovered so far, 100 belong to 
the lycopodine class.  
 
 
 
Figure 5. Some representative alkaloids belonging to the Lycopodine class. 
 
4.1. Previous synthesis of Lycopodine and related compounds 
 
 Along with the Fawcettimine nucleus, the synthesis of lycopodine has 
been one of the most intensively studied, with most of the approaches 
reported to date relying on a common D→C→B→A ring construction 
strategy. The key ring-forming step usually involves the manner of formation 
of the B ring, which can be divided into two main approaches. The first, 
described by Stork, involves an intramolecular Pictet-Spengler cyclization 
onto an iminium group located between the D and C rings. The aromatic ring 
is then fragmented and used to form the required carbon atoms of the A ring. 
Padwa and Mori later arrived at the same key intermediate precursor in their 
synthetic approaches albeit by very different methods.  The other key strategy 
to form the B ring involves an intramolecular diastereoselective Mannich 
cyclization approach which was first reported by Heathcock (see Scheme 4). 
This strategy, and variations thereof, has been the most commonly employed 
in subsequent synthetic approaches. The first enantioselective synthesis of a 
lycopodine related compound, clavolonine A was described by Evans and 
used a similar Mannich strategy. However, instead of following Heathcock 
and starting from a racemic D ring building block, a chiral auxiliary strategy 
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was used to form an acyclic chain which was then cyclised to form the D ring 
in enantiopure form. A few years later, Carter achieved the first 
enantioselective synthesis of lycopodine using an analogous approach to 
Evans employing a chiral auxiliary and a Mannich cyclisation as the key 
steps. Whilst a number of strategies do not fall into the categories described 
above, the methods employed have usually required a significant amount of 
additional functional group manipulation steps and consequently these 
strategies have not been exploited in further synthetic approaches. 
 
Table 3. Summary of the most relevant previous syntheses of Lycopodine and its 
derivatives. (* denotes enantioselective synthesis). 
 
Year Natural Product         Author           Ring Construction 
Strategy 
1967 [30] 12-epi-Lycopodine Weisner D→C→B→A 
1968 [31] 12-epi-Lycopodine Weisner D→C→A→B 
1968 [32] Lycopodine Stork D→C→B→A 
1968 [33] Lycopodine Ayer BC→A→D 
1978 [34] Lycopodine Heathcock D→C→B→A 
1978 [35] Lycopodine Kim D→B→C→A 
1982 [28] Lycopodine Schumann D→C→B→A 
1982 [21] Lycopodine Heathcock D→C→B→A 
1984 [36] Lycopodine Wenkert C→A→B→D 
1985 [37] Lycopodine Kraus D→B→C→A 
1998 [38] Lycopodine Mori D→B→C→A 
1998 [39] Lycopodine Grieco B→D→CA 
1997 [40] Lycopodine Padwa acyclic→CD→B→A 
2005 [41] Clavolonine Evans acyclic→D→C→B→A* 
2008 [42] Lycopodine Carter acyclic→D→C→B→A* 
2010 [43] Acetylfawcettiine Breit D→C→B→A* 
2011 [44] Clavolonine Fujioka D→C→B→A* 
2012 [45] 7-hydroxylycopodine Snider D→C→B→A 
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4.2. Heathcock’s synthesis of Lycopodine [21] 
 
 Key to Heathcock’s synthesis is an equilibrating Mannich cyclisation 
reaction which assembles the DCB tricyclic in a single step. The requisite 
material required for the cyclisation was prepared from                                        
5-methylcyclohexane-1,3-dione, which underwent Michael addition to 
acrylonitrile followed by formation of the cyclohexenone. Conjugate addition 
of a tosyl hydrazine to 9 followed by hydrolysis of the hydrazone gave 15. 
Protection of the ketone moieties as acetals then allowed the nitrile to be 
reduced to the primary amine. Treatment of 16 with strong acid over an 
extended period resulted in a diastereoselective Mannich cyclization to 
forming the DCB tricyclic system via equilibration to the most stable 
structure. Removal of the methoxyether group with HBr resulted in 
subsequent formation of the primary alkyl bromide, which was then cyclised 
onto the nitrogen under basic conditions giving lycopodine. 
 
 
 
Scheme 4. Heathcock’s total synthesis of Lycopodine. 
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5. Fawcettimine class  
  
 About a third of all the known lycopodium alkaloids are of the 
fawcettimine type. Key structural variations to the parent structure include 
skeletal oxidations as well as the formation of dimeric products. The 
fawcettimine nucleus can be simplified to the three-ring DBA system since 
the C ring forms spontaneously via the free amine condensing with the 
carbonyl to form the hemiaminal unit. 
 
 
 
Figure 6. Representative compounds of the Fawcettimine class. 
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5.1. Previous synthesis of Fawcettimine and related compounds 
 
 Fawcettimine-type products have been the area of most intensive 
synthetic research in the field of Lycopodium alkaloids, with the vast majority 
of syntheses being reported from 2007 onwards [46].
 
 
Table 4. Previous synthesis of Fawcettimine and related compounds. (* denotes 
enantioselective synthesis). 
 
Year Natural Product Author            Ring Construction 
    Strategy 
1979 [47] Fawcettimine Inubushi D→B→A→C 
1986 [48] Fawcettimine Heathcock D→B→A→C 
1989 [49] Fawcettimine Heathcock D→B→A→C 
2002 [50] Magellanine Liao BC→ A→D 
2007 [51] Fawcettimine Toste D→B→A→C* 
2008 [52] Fawcettidine Dake D→C→B→A* 
2010 [53] Fawcettimine 
(Fawcettidine) 
Takayama acyclic→DB→A→C* 
2010 [54] Fawcettimine Jung D→B→A→C* 
2010 [55] Fawcettimine 
(Lycoposerramine-B) 
Mukai acyclic→DB→A→C* 
2010 [56] Fawcettimine 
+(Lycoflexine) 
Yang D→B→A→C* 
2010 [57] Lycoflexine 
(Fawcettimine) 
Mulzer D→BA→C* 
2011 [58] Huperzine-Q Takayama acyclic→DB→A→C* 
2010 [59] Alopecuridine Meng D→A→B→C 
2012 [60] Fawcettimine Willliam D→A→B→C* 
2012 [61] Fawcettimine (Fawcettidine  
and Deoxyserratinine) 
Lei D→A→B→C* 
2013 [62] Lycojaponicumin C 
8-Deoxyserratinine 
Fawcettimine 
Fawcettidine 
Zhao D→B→A→C* 
2013 [63] Lycopladine D, Fawcettidine 
Lycoposerramine Q 
Tu DB→A→C* 
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 As a consequence most of the syntheses carried out are enantioselective 
with 3-methyl cyclohexenone 8 (derived from pulgeone) as the most popular 
source of chirality. As in all the previous syntheses of the Lycopodium 
alkaloids one strategy dominates for the construction of the fawcettimine 
skeleton. Most methods employ the D→B→A→C order (see Table 4) with 
the key differences in strategy centring on the assembly of the 5-membered B 
ring. This usually involves a conjugate addition onto a suitably substituted 
cyclohexenone followed by a subsequent trapping of the nucleophile via the 
formed carbonyl enolate. In a number of cases the order is reversed, with the 
6-membered D ring being appended onto a 5-membered B ring starting 
material precursor, for example, using a Diels-Alder [60] or a Robinson 
annulation reaction [62] Alternatively, the 6,5-bicycle (D-B) core has been 
constructed in a single step from an acyclic precursor using a Pauson-Khand 
reaction [53,55].    
 Subsequent closure of the 9-membered A ring usually involves a 
Mitsunobu-type reaction. Finally, deprotection of the nitrogen yields the free 
amine, which then spontaneously cyclises via the hemiaminal to close the C 
ring.  
 
5.2. The Mulzer synthesis of Lycoflexine and Fawcettimine  
 
 Mulzer and co-workers [57] have reported an efficient route to construct 
the 6,5,9-tricylic framework of fawcettimine which features an enyne ring-
closing-metathesis to construct the B and A rings in a single step. Like many 
Lycopodium syntheses it utilises 3-methylcyclohexenone 8 as the starting 
material and source of chirality. A Sakurai-aldol sequence gave substituted 
cyclohexanone 17 which after oxidation with IBX was alkylated with a 
nitrogen-containing side chain. Conversion of the methyl ketone to an alkyne 
prepared the starting material 18 for the tandem cyclization reaction. 
Treatment with Grubbs II catalyst initiated the enyne ring-closing-metathesis 
first forming the five-membered B ring followed by the 9-membered A ring. 
The resulting diene was hydrogenated in-situ to selectively remove the less 
substituted alkene. The remaining alkene then underwent a hydroboration-
oxidation sequence using IBX as the oxidant to directly introduce the desired 
ketone in the cyclopentane ring system. Deprotection of the Boc group 
liberated the secondary amine which underwent spontaneous cyclisation to 
fawcettimine. The addition of formaldehyde precipitated a Mannich reaction 
to give lycoflexine. 
Ben Bradshaw et al. 160 
 
   
Scheme 5. Mulzer’s total synthesis of (+)-lycoflexine. 
 
6. Conclusions 
 
 An overview of the synthetic approaches used to construct the four core 
structural types of the Lycopodium alkaloids has been presented. As can be seen, 
for each nucleus type one ring construction strategy tends to dominate for each 
nucleus type and there exists significant similarity between the starting materials 
and intermediates employed across the range of different approaches. There are 
now efficient procedures for the rapid construction of each nucleus type, using 
tandem reactions that construct many of the rings in a single step. It is hoped that 
continuing work within this field will lead to new and more efficient approaches 
to the Lycopodium alkaloids and their analogs that will enable a full investigation 
of their important biological activities for the treatment of serious diseases such 
as Alzheimer’s or cancer. 
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